These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 507334)

  • 1. [Clinical and morphological parallels in the hormonal therapy of endometrial hyperplastic processes].
    Lukina EL
    Akush Ginekol (Mosk); 1979 Oct; (10):34-7. PubMed ID: 507334
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormonal status of patients with hyperplastic endometrial processes in the postmenopausal period].
    Savel'eva GM; Breusenko VG; Iurovskiĭ SL
    Akush Ginekol (Mosk); 1986 Nov; (11):8-13. PubMed ID: 2949669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cystic glandular endometrial hyperplasia].
    Nilsen A
    Tidsskr Nor Laegeforen; 1977 Mar; 97(7):350-1. PubMed ID: 847691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined hormone therapy in hyperplasia of the endometrium].
    Bespoiasnaia VV; Tumasian KP; Voronovskaia IV
    Lik Sprava; 2000 Sep; (6):49-52. PubMed ID: 11452920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy and the risk of cancer in the climacteric].
    Kuhl H; Taubert HD
    Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
    Beliaeva LA; Bukhvalov IB; Zheleznov BI; Raĭkhlin NT
    Arkh Patol; 1982; 44(4):18-25. PubMed ID: 7082195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperplastic processes in the endometrium of women of child-bearing age using different types of synthetic progestins].
    Manuilova IA; Sotnikova EI
    Akush Ginekol (Mosk); 1978 Mar; (3):39-42. PubMed ID: 347966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic activity of the endometrium during treatment with synthetic progestins].
    Rotkina IE; Tsibizova SA
    Akush Ginekol (Mosk); 1977 Dec; (12):36-9. PubMed ID: 605978
    [No Abstract]   [Full Text] [Related]  

  • 10. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal hemostasis in dysfunctional uterine hemorrhages].
    Kheĭfets SN; Fadeeva NI
    Akush Ginekol (Mosk); 1979 Oct; (10):57-9. PubMed ID: 507343
    [No Abstract]   [Full Text] [Related]  

  • 12. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The menopause. Therapeutic measures].
    Rozenbaum H
    Rev Fr Gynecol Obstet; 1985 Mar; 80(4):227-9. PubMed ID: 3992125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.
    Bahamondes L; Ribeiro-Huguet P; de Andrade KC; Leon-Martins O; Petta CA
    Acta Obstet Gynecol Scand; 2003 Jun; 82(6):580-2. PubMed ID: 12780432
    [No Abstract]   [Full Text] [Related]  

  • 15. [Restoration of the menstrual and generative functions in genital endometriosis after treatment with various types of synthetic progestins].
    Nagovitsina AI; Teleliutina FK; Kravchuk TA
    Akush Ginekol (Mosk); 1980 Oct; (10):47-9. PubMed ID: 7446857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The menopause. Therapeutic regimens].
    Derrien J
    Rev Fr Gynecol Obstet; 1985 Mar; 80(4):223-5. PubMed ID: 3992124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New preparations for treatment of climacterial disorders].
    Nesheim BI
    Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface ultrastructural response of the human uterine lining epithelium to hormonal environment. A scanning electron microscopic study.
    Ferenczy A
    Acta Cytol; 1977; 21(4):566-72. PubMed ID: 269610
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of the Norcolut preparation in gynecologic; practice].
    Bozhinova S
    Akush Ginekol (Sofiia); 1996; 35(3):50-1. PubMed ID: 9045566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norethindrone--a review of therapeutic applications.
    Taitel HF; Kafrissen ME
    Int J Fertil Menopausal Stud; 1995; 40(4):207-23. PubMed ID: 8520623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.